Anebulo Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Anebulo Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q3 2024.
  • Anebulo Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 20, 2024 was 25.9M shares, a 1.17% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 25.9M +300K +1.17% Sep 20, 2024 10-K 2024-09-25
Q1 2024 25.9M +300K +1.17% May 6, 2024 10-Q 2024-05-15
Q4 2023 25.9M +300K +1.17% Feb 6, 2024 10-Q 2024-02-13
Q3 2023 25.6M +2.26M +9.69% Sep 14, 2023 10-K 2023-09-22
Q1 2023 25.6M +2.29M +9.8% May 9, 2023 10-Q 2023-05-11
Q4 2022 25.6M +2.29M +9.8% Feb 8, 2023 10-Q 2023-02-10
Q3 2022 23.4M +24K +0.1% Sep 1, 2022 10-K 2022-09-09
Q1 2022 23.3M May 10, 2022 10-Q 2022-05-11
Q4 2021 23.3M Feb 11, 2022 10-Q 2022-02-11
Q3 2021 23.3M Sep 15, 2021 10-K 2021-09-22
Q2 2021 23.3M Jun 16, 2021 10-Q 2021-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.